Eiger BioPharmaceuticals Raises US$7.1 Million 'A' Round
PALO ALTO, California, February 26 /PRNewswire/ --
- Funding to advance novel Hepatitis C Virus (HCV) therapies against new targets
Eiger BioPharmaceuticals, Inc., a start-up biotechnology company…